There were many studies on irisin levels in NAFLD patients with diabetes and other diseases combined, but these studies could not be included in this meta-analysis due to not meeting the eligibility criteria. The gene discussed is FNDC5; the disease is metabolic dysfunction-associated steatotic liver disease.